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Abstract
Serotonin is an important signaling molecule in the periphery and in the brain. The 
hydroxylation of tryptophan is the first and rate- limiting step of its synthesis. In most 
vertebrates, two enzymes have been described to catalyze this step, tryptophan hy-
droxylase (TPH) 1 and 2, with expression localized to peripheral and neuronal cells, 
respectively. However, animals lacking both TPH isoforms still exhibit about 10% of 
normal serotonin levels in the blood demanding an additional source of the monoam-
ine. In this study, we provide evidence by the gain and loss of function approaches in 
in vitro and in vivo systems, including stable- isotope tracing in mice, that phenyla-
lanine hydroxylase (PAH) is a third TPH in mammals. PAH contributes to serotonin 
levels in the blood, and may be important as a local source of serotonin in organs in 
which no other TPHs are expressed, such as liver and kidney.
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1 |  INTRODUCTION
Serotonin (5- Hydroxytryptamine, 5- HT) is an ancient sig-
naling molecule produced by some bacteria and most if 
not all Eukaryota including numerous plants.1 Historically 
5- HT has been first extracted from the gastrointestinal tract 
and blood of mammals, by the groups of Erspamer2 and 
Rapport3 in 1937 and 1948, respectively. Still, it would 
take them until 1952 to discover, that they had found the 
same molecule.4 Only thereafter 5- HT was found in the 
central nervous system of vertebrates,5 where it acts as the 
main neurotransmitter in a network influencing most as-
pects of behavior and cognition and in the enteric neurons 
in the gut,6 being essential for normal gastrointestinal mo-
tility.7 However, almost all 5- HT in mammals are located 
outside of the brain being generated by enterochromaffin 
cells in the gut and then taken up and distributed in the 
bloodstream by platelets.8 Although less well- known, the 
peripheral 5- HT regulates a multitude of important bodily 
functions. Following its release from circulating platelets 
upon local activation or from tissue cells storing or pro-
ducing 5- HT, it affects processes spanning from hemo-
stasis9 and vascular tone,10 to metabolic regulation in gut, 
liver, fat tissue, and endocrine pancreas.1 5- HT is gener-
ated from the amino acid tryptophan (Trp) in a two- step 
enzymatic process. In the first and rate- limiting step, Trp 
is hydroxylated to 5- hydroxytryptophan (5- HTP), followed 
by its decarboxylation to 5- HT by aromatic amino acid 
decarboxylase (AADC). Tryptophan hydroxylase (TPH) 
was cloned in 1987 and found to be part of the aromatic 
amino- acid hydroxylase (AAAH) family of enzymes, also 
including phenylalanine hydroxylase (PAH) and tyrosine 
hydroxylase (TH).11 Until 2003, when knockout (KO) 
mouse models for TPH were described by us12 and oth-
ers,13 it was considered the only enzyme responsible for se-
rotonin synthesis in the brain and periphery. While in these 
animals peripheral 5- HT levels were drastically reduced, 
they surprisingly showed normal 5- HT levels in the brain. 
This led to the discovery of the TPH2, the neuron- specific 
TPH isoenzyme, and the coining of the “duality” concept 
for the serotonin system: It consists of two completely in-
dependent networks in neuronal and non- neuronal tissues 
controlled by the gene products of two different paralogous 
genes, Tph2 and Tph1, respectively and separated by the 
blood- brain barrier.14 The exclusive activity of TPH2 for 
neuronal 5- HT synthesis was confirmed shortly thereafter 
by the identification of a mouse strain with a naturally oc-
curring point- mutation,15,16 and a few years later conclu-
sively clarified by the generation of TPH2- KO models in 
mouse, rat, and pig, which were all lacking 5- HT in the 
brain17- 21 and the enteric nervous system.22 However, fur-
ther studies revealed that TPH1- deficient mice, although 
being totally devoid of TPH1 enzyme, still contain 5- HT 
in the bloodstream, amounting to about 10% of wild- type 
(WT) levels.13 These amounts of peripheral 5- HT remain 
unchanged in TPH1/TPH2- double KO animals, arguing 
that they are not contributed by TPH2 in the brain or the 
enteric nervous system.17 In this study, we aim to elucidate 
the source of the residual blood 5- HT, which together with 
the gut is the largest serotonin pool in the mammalian body, 
and identify the enzyme which functions as a third TPH in 
vivo.
2 |  METHODS
2.1 | Animals
Mice were maintained at the MDC animal facility in individu-
ally ventilated cages (Tecniplast, Italy) under specific pathogen- 
free, standardized conditions in accordance with the German 
Animal Protection Law. Mice were group- housed at a constant 
temperature of 21 ± 2°C with a humidity of 65 ± 5%, an artifi-
cial 12 hours light/dark cycle, and with free access to water ad 
libitum. All experimental procedures were performed accord-
ing to the national and institutional guidelines and have been 
approved by responsible governmental authorities (Landesamt 
für Gesundheit und Soziales (LaGeSo), Berlin, Germany).
TPH1- deficient12 and TPH2- deficient18 mice were cross- 
bred to generate TPH1/TPH2- double KO mice. PAHenu2 mice 
(PAH- KO) were obtained from Jackson Laboratories, USA 
and then cross- bred with TPH1- KO mice to generate TPH1/
PAH- double- KO animals. All animals except PAH- KO 
and TPH1/PAH- KO were fed a standard diet (0.25% so-
dium; ssniff, Soest, Germany). TPH1/PAH- double- KO and 
PAH- KO were routinely maintained under Phe- free diet 
(S0087- E745, Ssniff, Soest, Germany). To check the effect 
of standard Phe- rich diet on serotonin metabolism, animals 
were fed standard chow for 4 weeks prior to experiments.
The PAH inhibitor α- methyl- L- phenylalanine (α– MPA, 
Sigma- Aldrich, Germany) was administered intraperitone-
ally (ip) at a dose of 0.43 mg/g mouse weight every 12 hours 
for 2.5 days. The control animals were treated with saline.
13C11 L- tryptophan (Cambridge Isotopes, USA) was ad-
ministered ip to 18hrs starved mice at a dose of 30 mg/kg. 
Animals were sacrificed 4 hours after administration.
For organ and blood collection, animals were anesthe-
tized by ip injection of ketamine (100 mg/kg)/xylazine (10 
mg/kg)). Three hundred microliters of whole blood were 
collected into 1 ml syringes prefilled with 100 µL of hep-
arin and quickly transferred to Eppendorf tubes containing 
10 µL of perchloric acid (PCA) and 5 µL of 10 mg/mL of 
ascorbic acid, vortexed, centrifuged (20 000 ×g, 30 minutes, 
4°C) and the supernatant was frozen at −80°C until HPLC 
and LC- MS/MS measurements. Immediately after the blood 
collection, mice were transcardially perfused with ice- cold 
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PBS to remove blood, containing platelet 5- HT. Tissues were 
snap- frozen in liquid nitrogen and kept at −80°C until further 
analysis by HPLC, LC- MS/MS or 5- HTP generation assay.
2.2 | HPLC
Frozen tissue samples were homogenized in 710 µM ascor-
bic acid and 2.4% perchloric acid (Sigma- Aldrich, Steinheim, 
Germany), and precipitated proteins were pelleted through 
centrifugation (20 minutes, 20000 ×g, 4°C) and the collected 
supernatant was analyzed for serotonergic metabolites (Trp, 
5- HTP, and 5- HT) using high- sensitive reversed- phase high- 
performance liquid chromatography (HPLC) with fluoromet-
ric detection. Samples were separated over a C18 reversed 
phase column (LipoMare C18, AppliChrom, Oranienburg, 
and ProntoSIL 120 C18 SH, VDS Optilab, Berlin) at 20°C in 
a 10 mM potassium phosphate buffer (pH 5.0) (Sigma- Aldrich, 
Steinheim, Germany) with 5% methanol (Roth, Karlsruhe, 
Germany) and a flow rate of 0.8- 1.0 mL/min. The excitation 
wavelength was 295 nm and the fluorescent signal was meas-
ured at 345 nm. CLASS- VP software (Shimadzu, Tokyo, Japan) 
was used to analyze the peak parameters of chromatographic 
spectra and quantify substance levels, based on comparative cal-
culations with alternately measured external standards.
2.3 | 5- HTP generation assay in organ 
lysates and transfected cells
The 5- HTP generation assay was adapted from a previously 
published method from our lab.23 Frozen organs were ho-
mogenized in 75 mM Tris- acetate (pH 7.5) (Roth, Karlsruhe, 
Germany), sonicated, and briefly centrifuged. Lysates were 
incubated with catalase (2 mg/mL), ferrous ammonium sul-
fate (100 μM), 1,4- dithiothreitol (25 mM, Sigma- Aldrich, 
Steinheim, Germany) for 10 minutes at 30°C. Tris- acetate 
of 15 mM (pH 6.4) (Roth, Karlsruhe, Germany), 50 μM L- 
tryptophan, and 2 mM NSD1015 (Sigma- Aldrich, Steinheim, 
Germany) were added in a second incubation step at 37°C. 
The reaction was stopped by adding 2.4% perchloric acid 
(70%) (Sigma- Aldrich, Steinheim, Germany). The trypto-
phan hydroxylating activity in organs was determined by the 
accumulation of 5- HTP after 30 minutes of incubation. For 
the pharmacological inhibition of PAH activity, 140 mM α- 
MPA was added to the reaction.
HEK293 cells were seeded in 6 well plates and trans-
fected with a human PAH expression plasmid (Origene 
Technologies, USA) using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s protocols. Cell lysates were 
obtained 48 hours post- transfection and in vitro 5- HTP gen-
eration assay was performed as described for organ lysates.
2.4 | 5- HTP generation assay in primary 
hepatocytes
Murine primary hepatocytes were isolated and seeded with 
phenol red- free William E medium on collagen A coated 
dishes suitable for fluorescence microscopy. The cells were al-
lowed to adhere overnight, serum- starved for 12 hours, and the 
ex vivo 5- HTP generation assay was performed with the addi-
tion of 250 µM Trp and 250 µM 6- methyl- 5,6,7,8- tetrahydrop
terine for 2 hours. The assay was stopped by washing the cells 
with PBS and fixation with paraformaldehyde. NSD- 1015 
was not added to avoid cell death. For immunofluorescence 
analysis, the fixed cells were blocked for 30 minutes with 3% 
normal donkey serum in PBS, followed by incubation with the 
primary antibody against 5- HTP (1:250) (ImmunoStar, USA) 
in blocking solution overnight at 4°C. The next day, sections 
were washed with PBS three times for 15 minutes and incu-
bated with the secondary antibody solution in PBS for 2 hours 
at room temperature. The cells were washed again three times 
with PBS and VECTASHIELD mounting medium containing 
DAPI was added. Images were taken using an inverted micro-
scope (Keyence BZ- 9000, Japan). Stainings were quantified 
using the BZ- II Analyzer software (Keyence, Japan).
2.5 | LC- MS/MS
Tryptophan, its metabolites, and their 13C marked analogs 
were analyzed using HPLC and the triple quadrupole mass 
spectrometer Agilent 6470/1290 equipped with an AJS elec-
trospray ion source (Agilent Technologies Santa Clara, CA). 
An HPLC column (Phenomenex Synergi Hydro- RP 150 × 2 
mm, 4 µm, Aschaffenburg, Germany) was used as a station-
ary phase and a gradient of 0.1 % formic acid in water and 
methanol as a mobile phase.
The gradient started at 0.5 % methanol, held for 0.5 min-
utes, and was increased to 40 % methanol after 6.5 minutes 
and 95 % after 7 minutes. The run stopped after 15 minutes, 
the flow rate was 0.4 mL/min, the injection volume 2.5 µL.
All solvents in LC/MS/MS purity were purchased from 
Merck (Darmstadt, Germany).
The MS/MS transitions and ion source parameters were 
optimized using authentic standards purchased from Sigma- 
Aldrich (Munich, Germany). The detailed list of all transi-
tions is shown in Supplementay Table S1 and the ion source 
parameter in Supplementary Table S2.
The system was calibrated in the range from 0.2 to 200 
ng/mL with eight levels for each compound. The calibration 
curves of 12C analogs were used also for 13C- metabolites. The 
linear regression was calculated using Agilent Mass Hunter 
software. The lower limit of quantification and the coefficient 
of determination are shown in Supplementary Table S3.
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2.6 | Generation of multiple sequence 
alignment and phylogenetic tree
Protein sequences were retrieved from the NCBI protein database 
in “FASTA”- format. Multiple sequence alignment (MSA) was 
performed in RStudio using the “msa” package and “ClustalW” 
alignment algorithm. The phylogenetic tree was estimated via 
the maximum likelihood method using the “phangorn” package. 
The final figure was generated via the “ggtree” package.
2.7 | Statistics
All data were subject to statistical analysis using R (version 
4.0.2) and RStudio (version 1.3.959). The results shown in 
this study represent mean values ± standard error of mean 
(SEM), unless stated otherwise. Tests defining the level of 
significance included Student’s t test to compare independ-
ent pairs of means, while more than two groups were ana-
lyzed by one- way ANOVA with Bonferroni post hoc test. 
Results with P  <  .05 were considered to be significantly 
different.
2.8 | Schematic drawings
The schematic drawing shown in Figure 4A was created with 
BioRender (BioRender.com).
3 |  RESULTS
3.1 | PAH is the most promising candidate 
for Trp hydroxylation
In order to confirm that TPH2 does not contribute to the pro-
duction of residual serotonin in the blood of TPH1- KO mice, 
we measured the blood and organ levels of 5- HT in TPH1- KO 
and TPH1/TPH2- double KO animals. Indeed, both strains 
equally exhibited around 10% of WT 5- HT levels in the blood 
as previously reported (Figure 1A).17 The 5- HT concentration 
in spleen, the main place of platelet breakdown and release 
of the serotonin contained within them, was coherent with 
5- HT levels in the circulation (Figure 1A). In the duodenum, 
serotonin was nearly undetectable in both lines demonstrat-
ing that TPH1 is the main serotonin- synthesizing enzyme in 
F I G U R E  1  PAH is a candidate for serotonin synthesis in mammals. A, 5- HT levels in blood, spleen, brain, and duodenum of wild- type 
(WT), TPH1- KO, and TPH1/TPH2- double KO mice. **P < .01, ***P < .001, ****P < .0001, one- way ANOVA with Bonferroni post hoc test. 
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this organ and that the contribution of TPH2 in myenteric 
neurons is negligible (Figure 1A). Moreover, we verified 
the mere absence of serotonin in the brain of TPH2- KO ani-
mals18 and the unchanged central levels in TPH1- KO mice12 
(Figure 1A). Next, we searched the literature for enzymes that 
could potentially complement TPHs by catalyzing the rate- 
limiting 5- hydroxylation of the indole- ring. This reaction is 
reported to be performed by only two families of enzymes: 
cytochrome- dependent monooxygenases (CYPs)24 and 
biopterin- dependent monooxygenases of the AAAH family.25 
Since the conversion of tryptamine to serotonin by CYPs was 
only shown in plants,24 we focused on the AAAH- family of 
monooxygenases that include the two known TPH enzymes, 
as well as PAH and TH. To narrow down a possible candi-
date, we checked for sequence homology between the two 
TPHs, PAH and TH from human, mouse, and rat and com-
pared them to Drosophila tryptophan- phenylalanine (DTPH) 
and tryptophan (DTRH) hydroxylases and the ancient PAH 
from the early metazoan/communal protozoan Dictyostelium 
discoideum (DictyoPAH), thought to be one of the most pri-
mal AAAHs (Figure 1B). Homology between the TPH- and 
PAH- families was overall higher than between THs and ei-
ther of both families. DTRH showed high homology to the 
TPH- family, DTPH, and DictyoPAH to the PAH- family. This 
fits data from the published literature showing that DTRH, 
DTPH, and dicytoPAH are all able to hydroxylate both, 
Phenylalanine (Phe) and Trp, but not tyrosine.26,27 Moreover, 
partially purified preparations of mammalian PAH displayed 
Trp hydroxylating activity in vitro.25,28,29 Furthermore, TH is 
unlikely to contribute to the production of 5- HT since brain 
serotonin levels in both TPH2- KO18 and TPH1/TPH2- double 
KO animals (Figure 1A) are close to zero and TH is primarily 
expressed in the brain. These considerations prompted us to 
prioritize PAH as a potential third key mammalian enzyme 
able to catalyze the first step of serotonin synthesis.
3.2 | PAH readily hydroxylates Trp to  
5- HTP in vitro
First, we expressed mouse PAH in HEK cells. Cells expressing 
PAH were able to hydroxylate Trp to 5- HTP, while untrans-
fected cells or cells transfected with an empty vector as expected 
were unable to do so due to the lack of endogenous expression 
of enzymes required for 5- HTP synthesis (Figure 2A).
Since PAH is primarily expressed in the liver, we used its 
homogenates for the in vitro 5- HTP generation assay. Trp hy-
droxylation to 5- HTP was readily observed in liver lysates from 
WT mice (Figure 2B). However, when we added the specific 
PAH- inhibitor alpha- methylphenylalanine (α- MPA),30 a signif-
icant decrease of nearly 80% in Trp hydroxylation was observed 
(Figure 2B). We further confirmed that liver Trp hydroxylation 
was independent of TPH expression since 5- HTP synthesis 
rates in liver lysates from both TPH1 and TPH1/TPH2- KO an-
imals were similar to WT (Figure 2C). In contrast, 5- HTP syn-
thesis was nearly abolished in liver lysates from PAH- deficient 
mice (Figure 2C). PAH- deficient animals develop phenylke-
tonuria characterized by high plasma and tissue concentrations 
of Phe, which are known to inhibit AAAHs.31 To exclude any 
inhibitory effect of Phe on TPH activity, we confirmed the lack 
of Trp hydroxylating activity in liver lysates from PAH- KO 
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Next, we cultured primary cells from the mouse liver to 
investigate the ability of hepatocytes to hydroxylate Trp to 5- 
HTP. While the supplementation of culture medium with Trp 
led to increased 5- HTP generation in WT and TPH1- KO he-
patocytes as shown by immunohistochemistry, PAH- deficient 
cells isolated from TPH1/PAH- double KO mice were unable 
to generate 5- HTP (Figure 2D).
3.3 | PAH contributes to 5- HT- generation 
in vivo
Next, we treated TPH1- KO mice with the PAH inhibitor α- 
MPA. Here we saw a reduction of whole- blood 5- HT levels 
by about 75%, indicating that the remaining blood 5- HT in 
TPH1- KO- mice is mainly dependent on PAH- mediated Trp 
hydroxylation (Figure 3A).
In order to further evaluate the importance of PAH- 
dependent Trp hydroxylation for blood 5- HT levels, we used 
TPH1/PAH double- KO mice. Here we also fed animals with 
Phe- free diet to prevent TPH inhibition by excessive amounts 
of Phe. Indeed, PAH- KO animals under normal diet exhibited 
markedly reduced blood 5- HT levels, while under a Phe- free 
diet they showed peripheral 5- HT levels comparable to WT 
mice (Figure 3B). These data are in line with previously reported 
effects of Phe- free diet on brain 5- HT levels in PAH- KO mice 
and in patients suffering from phenylketonuria.31 Strikingly, in 
the novel TPH1/PAH, double- KO mouse model 5- HT in the 
blood was close to the lowest detection limit and amounted to 
about 1% of WT levels independently of the diet (Figure 3B).
Next, we directly measured the in vivo 5- HT neo- synthesis 
by a 13C stable- isotope resolved mass spectrometry (SIRM)- 
based approach (Figure 4A). Trp has been shown to be prone 
to label- loss when a 3H- label is used32 and therefore previous 
studies have used 15N- labeled33 or 13C- labeled Trp34,35 to as-
sess the peripheral 5- HT synthesis in dogs, rats, and humans. 
When we injected animals with 13C- labeled Trp, it was read-
ily converted to 5- HT in WT and PAH- KO mice as detected 
in blood by LC- MS/MS (Figure 4B,C). As expected, con-
version was markedly reduced, but still measurable in TPH1 
and TPH1/TPH2- double KO mice. However, no 13C- labeled 
5- HT could be detected in the blood of TPH1/PAH- double 
KO mice (Figure 4C) finally confirming the contribution of 
PAH to Trp hydroxylation in vivo.
4 |  DISCUSSION
In this study, we provide several lines of evidence revealing 
PAH as the third tryptophan hydroxylating enzyme in mice 
and likely in other mammals: (1) mice lacking both known 
TPH isoforms, TPH1 and TPH2, still have about 10% of nor-
mal serotonin levels in the blood; (2) additional genetic or 
pharmacological blockade of PAH drastically reduces this 
leftover; (3) cells overexpressing PAH gain Trp hydroxy-
lating activity; (4) in vitro Trp hydroxylation takes place in 
liver extracts and cultured hepatocytes from WT but not from 
PAH- KO mice; 5) isotope- labeled Trp is metabolized to ser-
otonin in the periphery of WT and TPH1- KO mice but not of 
TPH1/PAH- double KO animals.
PAH has already been described as a Trp hydroxylase in 
invertebrates. In fact, PAH, encoded by the Henna gene, was 
for a long time the only known TPH in Drosophila and is still 
called DTPH. This error was based on the strong reduction of 
serotonin in the head of Henna mutant flies.36 Later it turned 
out that the absence of PAH caused a dramatic increase in 
Phe and thereby an inhibition of the real TPH, which was 
then discovered as the product of the CG9122 gene, now 
called DTRH.26 Nevertheless, PAH also contributes signifi-
cantly to serotonin production in flies and is proposed to be 
responsible for peripheral, but not central 5- HT synthesis in 
these species.
Historically PAH was first suggested to be the main TPH 
also in mammals,25,37 until organs that lack PAH expression, 
such as the intestines, were found to contain high amounts of 
5- HT.38 Nevertheless, the first TPH gene was cloned by screen-
ing an expression library from the rabbit pineal body with an— 
obviously cross- reacting— antibody against rat PAH.11
The efficiency of PAH to hydroxylate Trp is lower than 
that of TPH.29 This is due to a crucial tryptophan- residue 
(W) in the active site of PAH that reduces the affinity to the 
substrate Trp.39 In TPH, a conserved phenylalanine residue 
(F) is found at the homologous position (Figure 5). If this 
active site amino acid residue is mutated to W, the prefer-
ence of TPH for the substrate Trp is reduced. Vice versa, a 
mutation of W to F causes PAH to be converted into a very 
efficient TPH.39 Figure 5 presents the superimposition of the 
crystal structures of the catalytically active domains of PAH 
and TPH and illustrates the general ability of PAH to bind 
Trp as substrate. However, the side chain of the W residue is 
positioned only 3 Ångstrom away from the substrate- binding 
F I G U R E  2  PAH is a tryptophan hydroxylating enzyme in 
vitro. A, In vitro 5- HTP generation in lysates from HEK293 cells 
either untransfected or transfected with empty vector (pcDNA3.1) or 
vector expressing PAH. B, In vitro 5- HTP production at baseline and 
following PAH- inhibition by α- MPA in liver lysates harvested from 
wild- type (WT) animals. C, In vitro 5- HTP generation in liver lysates 
harvested from WT, TPH1, TPH1/TPH2, and PAH- deficient animals 
under standard chow or phenylalanine- free (Phe- free) diet. D, 5- HTP 
accumulation in primary hepatocytes from WT, TPH1, and TPH1/
PAH animals incubated with Trp for 2 hours. Micrographs represent 
cells immunofluorescently labeled with DAPI (blue) and anti- 5- HTP 
antibodies (red). 5- HTP can be detected in hepatocytes harvested from 
WT and TPH1 animals but not in hepatocytes harvested from TPH1/
PAH animals. ***P < .001, ****P < .0001, one- way ANOVA with 
Bonferroni post hoc test
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site and thus influences substrate binding both sterically and 
by hydrophobic interactions.
The 5- HT levels in TPH1/PAH- double KO mice were 
drastically reduced in comparison to TPH1- KO animals, but 
still detectable at about 1% of WT mice. This finding raises 
the question: What are the possible sources for this leftover? 
One option is a spillover of TPH2- generated 5- HT from 
brain.40 Enteric serotonergic neurons could also serve as a 
F I G U R E  3  Pharmacological inhibition or genetic ablation of PAH activity reduces blood 5- HT levels in vivo. A, Blood 5- HT levels in TPH1- 
KO mice treated either with saline (vehicle) or PAH- inhibitor α- MPA. B, Blood 5- HT levels in TPH1- KO, PAH- KO, and TPH1/PAH- double KO 
animals either on a standard chow or a phenylalanine- free (Phe- free) diet. Data are presented as % of WT blood 5- HT levels. **P < .01, ***P < 
.001, ****P < .0001, ns, not significant, one- way ANOVA with Bonferroni post hoc test
(A) (B)
F I G U R E  4  Animals lacking TPH1 and PAH show no 5- HT neo- synthesis as detectable via stable- isotope resolved mass spectrometry. A, 
Experimental setup. Mice were treated with 13C- labeled Trp and their blood was evaluated for fully 13C- labeled 5- HT via LC- MS/MS. B, 13C- 
labeled Trp and c 13C- labeled 5- HT levels in the blood of WT, TPH1- KO, TPH1/TPH2- double KO, PAH- KO, and TPH1/PAH- double KO mice 
4 hrs after 13C- Trp treatment. PAH- KO and TPH1/PAH- double KO animals were kept on a Phe- free diet. *P < .05, **P < .01, one- way ANOVA 
with Bonferroni post hoc test
(A)
(B) (C)
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source of these minute amounts of 5- HT. Although 5- HT re-
leased at synapses are unlikely to escape the enteric nervous 
system without prior metabolism due to the high activity of 
the serotonin transporter and organic cation transporters,41 
this scenario can also not be excluded. Since we were as of 
yet unable to generate TPH1/TPH2/PAH- triple- KO mice, we 
could not test these hypotheses.
A second possibility is the uptake of 5- HT from the gut 
lumen, where it is either present in the food or produced by 
gut bacteria. Food serves as the primary supply of Trp for 
mammals and even contains detectable amounts of 5- HT.42 
Besides their stimulating effect on serotonin synthesis in the 
enterochromaffin cells of the gut,43,44 enteric bacteria have 
also been shown to synthesize and react to 5- HT and may 
contribute to its luminal levels.44,45 Its uptake from the gut 
lumen is possible in small amounts, as already shown in ear-
lier studies by giving food rich in serotonin, eg, bananas46 or 
by the oral administration of the monoamine in high concen-
tration.47 The standard mouse food used in our study contains 
about 0.5 µg/g 5- HT. Mice consume about 4 g of food daily. 
This, together with the bacterial 5- HT production and me-
tabolism, results in about 2- 4 µg 5- HT daily passing through 
the gut. This food- or bacteria- supplied 5- HT may contrib-
ute to the residual traces found in the blood of mice lacking 
serotonin- producing enzymes in the periphery (TPH1/PAH- 
double KO). That being said, the mechanisms of such uptake 
would still have to be clarified.
The physiological role of PAH- derived 5- HT remains to 
be determined, but it may be important under certain (patho)
physiological conditions. Moreover, since local 5- HT gener-
ation and signaling, with no spillover into the reservoir of the 
blood, has been shown in several organs, such as pancreas, 
fat, and mammary glands,1,48- 50 it is reasonable to expect the 
physiological effects of PAH- derived 5- HT in the main PAH- 
expressing organs (liver and kidney) in which no other TPHs 
are expressed.
For the liver, numerous physiological and pathophysiologi-
cal effects have been assigned to serotonin, such as the stimula-
tion of regeneration, aggravation of fibrosis, and amelioration 
of virus infection.51- 53 However, most of these effects were 
abolished in TPH1- KO mice showing that gut- and platelet- 
derived serotonin is the main mediator in these situations.
Little is known about the possible 5- HT functions in the 
kidney, the second site of PAH expression in mammals.54,55 
Since kidneys do not express either TPH,54 PAH is likely to 
be the main source of the locally generated 5- HT. There are 
several 5- HT receptors including 5- HT2A and 2B in kidney 
and their effects on blood flow and sodium absorption have 
been described.55,56 However, the relevance of these findings 
for normal kidney physiology and renal diseases is yet to be 
established.
The role of PAH- derived 5- HT in physiology could be 
studied in PAH- KO mice, but these animals suffer from 
phenylketonuria and the high phenylalanine levels confound 
physiological analyses. Nevertheless, our study is the first 
step in understanding the importance of PAH as third 5- HT 
synthesizing enzyme and future studies are warranted to clar-
ify its role in particular in liver and kidney possibly using ani-
mal models with organ or cell- type- specific reduction of PAH 
activity.
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F I G U R E  5  Human PAH crystal structure analysis. A 
superimposition of the crystal structures of the catalytic domains of 
human PAH (PDB ID 1mmk,57) and chicken TPH1 (PDB ID 3e2t,58) 
is shown. The cartoon model of the overall fold is displayed in light 
orange (PAH) and grey (TPH1), respectively. The PAH crystal 
structure is complexed with iron (FeII, orange sphere), the cofactor 
tetrahydrobiopterin (BH4), and the substrate analog 3- (2- thienyl)- L- 
alanine (THA) (orange stick models), TPH1 is bound to tryptophan 
(Trp, green stick model). The interior surface (light blue) of the 
active- site cavity of PAH was calculated with the program Hollow 
and displayed with PyMOL Molecular Graphics System (Version 
1.3, Schrödinger, LLC). The superimposition illustrates that the PAH 
active site is generally capable of Trp binding. However, in PAH, 
the efficiency of Trp conversion is diminished by the presence of the 
bulky side chain of a Trp residue (W326 in human PAH, orange stick 
model) that is positioned only 3 Ångstrom away from the substrate- 
binding site and thus influences substrate binding both sterically and 
by hydrophobic interactions (red dashed line). In comparison, in TPH, 
a phenylalanine residue is conserved at this position (F314 in chicken 
TPH1, green stick model)
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